Literature DB >> 1333121

Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host.

R Freund1, T Dubensky, R Bronson, A Sotnikov, J Carroll, T Benjamin.   

Abstract

We have determined the tumor responses of nine inbred mouse strains and of two F1 hybrids following inoculation with polyoma virus. The results showed wide variations in the frequencies of mice developing tumors. Correlation with H-2 haplotype were evident. C3H/BiDa mice of H-2k type were fully susceptible, while C57BL/6 mice of H-2b type were completely resistant. DBA/2 and BALB/c mice, both H-2d, were of low susceptibility. Contributions of the major histocompatibility complex were demonstrated using pairs of H-2 congenic mice. Substitution of H-2k on either a BALB/c or a C57BL/10 background resulted in an increase in the frequencies and kinds of tumors induced. Susceptibilities of BALB and C57BL mice bearing the H-2k haplotype were still well below those of C3H/BiDa mice, however. Crosses of C3H/BiDa with BALB/c or BALB.K (H-2k) produced F1s that were of moderate and full susceptibility, respectively. These results indicate two distinct classes of host genes, one at the H-2 locus where different alleles confer varying degrees of resistance and the other a dominant susceptibility gene(s) carried in C3H/BiDa mice.

Entities:  

Mesh:

Year:  1992        PMID: 1333121     DOI: 10.1016/0042-6822(92)90248-n

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  SJL/J mice are highly susceptible to infection by mouse adenovirus type 1.

Authors:  K R Spindler; L Fang; M L Moore; G N Hirsch; C C Brown; A Kajon
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner.

Authors:  Qingsong Qin; Elizabeth L Frost; Saumya Maru; Aron E Lukacher
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

4.  Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors.

Authors:  P Velupillai; I Yoshizawa; D C Dey; S R Nahill; J P Carroll; R T Bronson; T L Benjamin
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Oncogenesis of mammary glands, skin, and bones by polyomavirus correlates with viral persistence and prolonged genome replication potential.

Authors:  J J Wirth; L G Martin; M M Fluck
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Gamma interferon controls mouse polyomavirus infection in vivo.

Authors:  Jarad J Wilson; Eugene Lin; Christopher D Pack; Elizabeth L Frost; Annette Hadley; Alyson I Swimm; Jun Wang; Ying Dong; Cynthia P Breeden; Daniel Kalman; Kenneth A Newell; Aron E Lukacher
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

7.  Radiation-resistant and radiation-sensitive forms of host resistance to polyomavirus.

Authors:  J P Carroll; J S Fung; R T Bronson; E Razvi; T L Benjamin
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control.

Authors:  Rabinarayan Mishra; Bojan Polic; Raymond M Welsh; Eva Szomolanyi-Tsuda
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

Review 9.  Immunity to polyomavirus infection: the polyomavirus-mouse model.

Authors:  Phillip A Swanson; Aron E Lukacher; Eva Szomolanyi-Tsuda
Journal:  Semin Cancer Biol       Date:  2009-02-14       Impact factor: 15.707

Review 10.  Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer.

Authors:  Brian S Schaffhausen; Thomas M Roberts
Journal:  Virology       Date:  2008-11-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.